three mg/ml) as substrates. A. xylosoxidans ATCC 27061 and P. aeruginosa ATCC
3 mg/ml) as substrates. A. xylosoxidans ATCC 27061 and P. aeruginosa ATCC 27853 had been incorporated as unfavorable controls and clinical isolates of P. aeruginosa expressing IMP-13 or VIM-2 metallo-lactamases…